Live from the NIH registry
Studies recruiting near Galveston right now
Top 25 of 201 recruiting studies, sorted by proximity — each links to its official registry page
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
Allure Health at Mt. Olympus Medical Research — Friendswood, Texas (26.9 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.
Herpes Zoster (HZ), Vascular Dementia
N/A
Observational 375 participants sought
Center for Clinical Studies, LTD. LLP — Webster, Texas (24.2 mi)
· Sponsor: Center for Clinical Studies, Texas
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
MD Anderson League City — League City, Texas (21.7 mi)
· Sponsor: Pfizer
Improving Sleep In Midlife Women
Poor Sleep Quality
N/A
Interventional 72 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: The University of Texas Medical Branch, Galveston
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
MD Anderson League City — League City, Texas (21.7 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
MD Anderson League City — League City, Texas (21.7 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,500 participants sought
UT MD Anderson - League City — League City, Texas (21.7 mi)
· Sponsor: NRG Oncology
Non-Invasive Preeclampsia Screening and Biobank
Preeclampsia (PE)
N/A
Observational 6,550 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: Sequenom, Inc.
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
ADHD
Phase 3
Interventional 468 participants sought
Clinical Research Site — Friendswood, Texas (26.9 mi)
· Sponsor: Axsome Therapeutics, Inc.
Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries
Spinal Cord Injuries, Urinary Incontinence
Phase 2
Interventional 24 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: The University of Texas Medical Branch, Galveston
XTX301 in Patients With Advanced Solid Tumors
Advanced Solid Tumor
Phase 1, Phase 2
Interventional 358 participants sought
Tranquil Clinical Research — Webster, Texas (24.2 mi)
· Sponsor: Xilio Development, Inc.
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
SLE, SLE (Systemic Lupus)
Phase 1
Interventional 24 participants sought
Tranquil Clinical Research — Webster, Texas (24.2 mi)
· Sponsor: Cullinan Therapeutics Inc.
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 961 participants sought
GSK Investigational Site — Webster, Texas (24.2 mi)
· Sponsor: GlaxoSmithKline
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
COVID-19
Phase 1
Interventional 80 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Webster, Texas (24.2 mi)
· Sponsor: Akero Therapeutics, Inc
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
Colorectal Cancer
Phase 2
Interventional 90 participants sought
The University of Texas MD Anderson Cancer Center — Texas City, Texas (9.4 mi)
· Sponsor: Kahr Bio Australia Pty Ltd
Feasibility and Adherence to a Technology-assisted Home-based Strength Training Program in Adults With Type 2 Diabetes Mellitus and Mild Cognitive Impairment
Type2diabetes, Mild Cognitive Impairment
N/A
Interventional 20 participants sought
University of Texas Medical Branch, Galveston — Galveston, Texas (6.7 mi)
· Sponsor: The University of Texas Medical Branch, Galveston
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer
Phase 2
Interventional 320 participants sought
MD Anderson League City — League City, Texas (21.7 mi)
· Sponsor: Pfizer
A Study to Evaluate the Maintenance Effect of Osavampator as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Major Depressive Disorder
Phase 3
Interventional 550 participants sought
Neurocrine Clinical Site — Friendswood, Texas (26.9 mi)
· Sponsor: Neurocrine Biosciences
Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
Breast Cancer, Breast-conserving Surgery
N/A
Interventional 10 participants sought
University of Texas Medical Branch at Galveston, TX — Galveston, Texas (6.7 mi)
· Sponsor: Innoblative Designs, Inc.
Tirzepatide to Slow Biological Aging
Aging, LONGEVITY 1
Phase 2
Interventional 90 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: The University of Texas Medical Branch, Galveston
A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting
Recessive Dystrophic Epidermolysis Bullosa
N/A
Observational 250 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: Abeona Therapeutics, Inc
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
AL Amyloidosis
Phase 3
Interventional 338 participants sought
Houston Methodist Saint John Hospital — Nassau Bay, Texas (23.7 mi)
· Sponsor: SWOG Cancer Research Network
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: Novo Nordisk A/S
A Study of V132 in Healthy Older Participants (V132-001)
Healthy
Phase 1
Interventional 280 participants sought
University of Texas Medical Branch ( Site 0004) — League City, Texas (21.7 mi)
· Sponsor: Merck Sharp & Dohme LLC